Adefovir

This page contains recent news articles, when available, and an overview of Adefovir but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Adefovir Plus Lamivudine Is Effective in Patients With Lamivudine-Resistance ...  -  ‎Nov 2, 2009‎
In patients with chronic HBV who are resistant to LMV, add-on adefovir strategy is superior to a switch strategy, as ADV monotherapy carries a significant ... DG News

Is chronic hepatitis B curable?  -  ‎Nov 12, 2009‎
Therapy is done using interferon-a, oral lamivudine and oral adefovir. On therapy, the virus will still remain in the body, however, as mentioned earlier, ... DoctorNDTV

BARACLUDE® (entecavir) Demonstrated Greater Antiviral Efficacy Compared to ...  -  ‎Oct 31, 2009‎
The study successfully met its primary objective; at Week 24, BARACLUDE achieved a greater reduction in viral load than adefovir: -4.48 (0.200) versus -3.40 ... Reuters

Entecavir Achieves High Response Rate In Real-life Clinical Management Of ...  -  ‎Nov 4, 2009‎
A further study showed that entecavir (1.0mg once daily) was superior to adefovir (10mg once daily) in achieving undetectable HBV DNA levels (< 300 ... Medical News Today

BiomedReports: News and FDA Updates for Bristol-Myers (NYSE:BMY), ICON (NASDAQ ...  -  ‎Nov 3, 2009‎
...(ETV-048) of chronic hepatitis B patients with decompensated cirrhosis, in which BARACLUDE demonstrated greater viral suppression compared to adefovir. ... Trading Markets (press release)

Interim data from Bristol-Myers Squibb's BARACLUDE study for chronic hepatitis ...  -  ‎Nov 2, 2009‎
...(ETV-048) of chronic hepatitis B patients with decompensated cirrhosis, in which BARACLUDE demonstrated greater viral suppression compared to adefovir. ... News-Medical.net

US stock market opening report (November 02, 2009, Monday)  -  ‎Nov 2, 2009‎
...chronic hepatitis B patients with decompensated cirrhosis, in which BARACLUDE demonstrated greater viral suppression compared to adefovir. ... Stock Markets Review

Bristol-Myers Squibb on Baraclude: Better efficacy than competitor  -  ‎Nov 3, 2009‎
Hepsera (adefovir) in 191 patients with chronic hepatitis B infection with severe cirrhosis of the liver, also known as decompensated cirrhosis. ... Drug Store News (blog)

Majority of Hep B patients resistant to antiviral therapy  -  ‎Oct 22, 2009‎
...(83%) and were currently on adefovir (ADV) and lamivudine (LAM) (39%), LAM (16%), ADV plus entecavir (ETV), ETV monotherapy (12%) or ETV 1mg (11%). ... Gastroenterology Update

Indicado para o tratamento do HIV, Tenofovir é efetivo contra a hepatite B  -  ‎Oct 27, 2009‎
Entre os novos medicamentos incluídos no protocolo de tratamento da hepatite nesta terça-feira (27) pelo Ministério da Saúde, Entecavir, Adefovir e ... G1.com.br

Droga para aids será usada no tratamento de hepatite  -  ‎Oct 26, 2009‎
Além do Tenofovir, o governo tinha como escolha adotar uma outra droga, o Adefovir, produzido pela multinacional GSK. Mas há pontos desfavoráveis. ... Estadão

Molecule noi pentru bolnavii HIV/SIDA şi de hepatita B  -  ‎Oct 26, 2009‎
Moleculele Adefovir, Tenofovir şi Emtricitabina sunt considerate prima opţiune de tratament pentru pacienţii recent diagnosticaţi sau pentru cei care nu mai ... Jurnalul Naţional

헵세�?�, 간�?��?후 B형간염 예방목�? 투여 �?�정  -  ‎Oct 22, 2009‎
...개정안�?� 보면 Adefovir dipivoxil 경구제(품명 : 헵세�?�정)와 Entecavir 경구제(품명 : 바�?��?�루드정 1mg, 시럽)�?� 경우 간�?��? 전�? Adefovir dipivoxil �?는 ... 메디게이트뉴스

Revista Isto É destaca novo protocolo de hepatites anunciado nesta semana pelo ...  -  ‎Oct 31, 2009‎
As drogas são o tenofovir, que também é usado no tratamento antiaids, o entecavir e adefovir. Segundo o Ministério da Saúde, os medicamentos estarão ... Agência de Notícias da Aids

GileadSciencesgibtRekord-Finanzergebnis für das dritteQuartal2009bekannt  -  ‎Oct 23, 2009‎
Weitere Antiviralprodukte Die Umsätze mit anderen Antiviralprodukten wie Hepsera® (Adefovir Dipivoxil) und Emtriva® (Emtricitabin) lagen im dritten Quartal ... Reuters

당신�?� 괴롭히는 만성B형간염, 얼마나 알고 있나?  -  ‎Oct 18, 2009‎
...다행히 최근 �?�미부딘�?� 내성 바�?�러스�? 효과를 나타내는 아�?��?�비어(adefovir)와 엔테카비어(entecavir)나 �?�레부딘(clevudine) 등과 같�?� 최신 항바�?�러스제가 ... 쿠키뉴스

Gilead Sciences gibt Rekord-Finanzergebnis für das dritte Quartal 2009 bekannt  -  ‎Oct 23, 2009‎
Die Umsätze mit anderen Antiviralprodukten wie Hepsera ® (Adefovir Dipivoxil) und Emtriva ® (Emtricitabin) lagen im dritten Quartal 2009 bei USD 74,7 ... WELT ONLINE

Chronische hepatitis B patiënt beter te behandelen  -  ‎Oct 25, 2009‎
Deze patiënten kunnen worden behandeld met peginterferon of met virusremmers (zoals adefovir, entecavir of tenofovir). Van het eerste middel is bekend dat ... Medical facts

B型�?炎基金會發表�?兒篩檢�?監控與轉診指引  -  ‎Oct 21, 2009‎
...目�?�?�得美國食�?藥物管�?�局核准用於孩童慢性B型�?炎�?步治療的抗病毒藥物，adefovir用於12歲以上者�?entecavir用於16歲以上者�?干擾素α-2b用於12個月以上 ... 臺灣新浪網

Evaluación del paciente con hepatitis B  -  ‎Oct 19, 2009‎
Lampertico P, Vigano M, Manenti E, Iavarone M, Lunghi G, Colombo M. Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic ... Intramed.net (Suscripción)

B형 간염 1차 약제 내성, '헵세�?�정 10mg' 급여  -  ‎Aug 12, 2009‎
...�?승정 기�? �?메디컬헤럴드신문】앞으로 B형 간염 1차치료제(lamivudine, clevudine, entecavir 0.5mg)�?� 내성�?� 발현�?� 경우 adefovir dipivoxil 경구제(품명 메디컬헤럴드

9월부터 �??경 후 호르몬제 등 약제 5항목 급여신설  -  ‎Aug 27, 2009‎
...했고 △B형 간염 1차 치료제(lamivudine, clevudine, entecavir 0.5mg) 내성�?� 발현�?� 경우 adefovir dipivoxil 경구제(품명: 헵세�?�정 10mg) 요양급여�?� �?�정했다. 메디포뉴스

La hepatitis B costará 1,84 billones de euros a los españoles en ...  -  ‎Jun 27, 2009‎
...un año para el tratamiento de la HBC y se presenta como la opción de rescate para pacientes resistentes a adefovir, solo o combinado con un nucleósido. acceso.com (Comunicado de prensa)

Pharmasset Voluntarily Halts Clinical Studies with Clevudine in ...  -  20 Apr 2009
...multi-center, randomized, double-blind clinical trials of 30mg once daily clevudine compared with 10mg once daily adefovir for 96 weeks in patients with PR Newswire (press release)

Liver disease and HIV  -  ‎Apr 14, 2009‎
Several previous clinical studies have assessed the efficacy of other medications such as lamivudine (3TC, Epivir), famcyclovir (Famvir) and adefovir ADVANCE for Physician Assistants

Profiting From China's Health-Care Reforms  -  ‎Apr 8, 2009‎
The company makes the hepatitis B drug Adefovir, which it expects to bring in sales of 80 million yuan ($11.7 million) to 100 million yuan ($14.6 million) Forbes

Hepatitis B treatment to take forward step  -  ‎Mar 30, 2009‎
...“Pegylated interferon adds to the antiviral treatments already available for this liver disease, these include interferon, lamivudine and adefovir. Scoop.co.nz (press release)

Vírus da hepatite B cria resistência a droga usada no SUS  -  ‎Apr 11, 2009‎
Entre elas estão o entecavir (Bristol), o adefovir (GSK) ea telbivudina (Novartis), além dos interferons peguilados. Segundo o médico Evaldo Stanislau Midiamax

Liver Disease and HIV  -  18 Mar 2009
13 Although adefovir is not cleared by the FDA for use as an antiretroviral, it has demonstrated activity against HBV along with its daughter compound, ADVANCE for LPNs

1st Annual Symposium of the New UK Drug Discovery Consortium Announced  -  ‎Feb 23, 2009‎
...and “Discovery of the acyclic nucleoside phosphonates cidofovir, adefovir and tenofovir as antiviral drugs - Professor Erik De Clercq (KU Leuven)�?. Newswire Today (press release)

HEPATITES ACTUALITE : Le traitement de l'hépatite B en 2008  -  ‎Mar 6, 2009‎
Avec l'adefovir, on dispose d'un recul prolongé de plus de 5 ans chez les malades Ag HBe négatif montrant une réponse stable et un taux de résistance faible ARCAT

Hépatites actualités 65: Le congrès américain d'hépatologie 2007 ...  -  ‎Mar 6, 2009‎
Ce nucléoside, utilisé chez les patients ayant développé une résistance à l'Adefovir, ne permet pas d'obtenir l'indétectabilité de l'ADN VHB (29). ARCAT

Drug treatments for hepatitis B  -  Jan 21, 2009
...[3] You take adefovir (Hepsera) as tablets. It's used when other treatments haven't worked, or if you can't take other treatments because of side effects. guardian.co.uk,

HBV prevalence in Kuwait around 2-5 pc, says Dr Fuad  -  Jan 25, 2009
...“Earlier a limited number of antiviral treatment options were available, including lamivudine and adefovir. While these treatments may be efficacious, Arab Times,

Clinical Trials Update: Jan. 26, 2009  -  Jan 26, 2009
If you are 18 or older, have hepatitis B, have never been treated with a nucleoside analogue such as Hepsera (adefovir dipivoxil), and meet additional Washington Post,

Entecavir: Resistance in Nucleoside-naive Chronic Hepatitis B Patients  -  Jan 12, 2009
Tenofovir disoproxil fumarate (TDF) for the treatment of HBeAg-positive chronic hepatitis B: week 72 TDF data and week 24 adefovir dipivoxil switch data Medscape

Gilead has Strong 4Q, but US HIV Drug Sales Down  -  Jan 28, 2009
The company's other hepatitis B drug, Hepsera (adefovir dipivoxil), generated sales of $76 million in the fourth quarter, which Washington noted was a 1 TMCnet

Gilead Sciences Announces Record Fourth Quarter and Full Year 2008 ...  -  Jan 28, 2009
Other antiviral product sales, including Viread® (tenofovir disoproxil fumarate), Hepsera® (adefovir dipivoxil) and Emtriva® (emtricitabine), increased five Lifescience-online,

慢性B型�?炎患者藥物治療新發�?�  -  Jan 28, 2009
...在美國，食�?藥物管�?�局(FDA)根據民國�?�??二年二月刊登於新英格蘭醫學雜誌兩篇慢性B型�?炎治療第三期人體試驗報導，核准新�?��?藥物Adefovir uho優活�?�康網,

*vwd/BUSINESS WIRE: Gilead Sciences gibt Rekord-Finanzergebnisse ...  -  Jan 30, 2009
Weitere Antiviralprodukte Der Umsatz bei den sonstigen Antiviralprodukten wie Viread^® (Tenofovir Disoproxil Fumarat), Hepsera^® (Adefovir Dipivoxil) und ddp-direkt.de (press release),

Gilead Sciences annonce des résultats financiers record pour le ...  -  Jan 29, 2009
Les ventes d’autres produits antiviraux, y compris celles de Viread ® (ténofovir disoproxil fumarate), d’Hepsera ® (adefovir dipivoxil) et d’Emtriva Boursier.com (Communiqué de presse),

Maga ellen játszott a gyártó  -  Jan 21, 2009
...napi egy adagos Vireadot (hatóanyag: tenofovil disproxil fumarate) és saját fejlesztése, a Hepsera (adefovir dipivoxil) ellenében tesztelte. Weborvos,

Gilead Sciences gibt Rekord-Finanzergebnisse für viertes Quartal ...  -  Jan 30, 2009
Der Umsatz bei den sonstigen Antiviralprodukten wie Viread ® (Tenofovir Disoproxil Fumarat), Hepsera ® (Adefovir Dipivoxil) und Emtriva ® (Emtricitabin) Business Wire (press release),

Tenofovir May Be More Effective Than Adefovir for Chronic ...  -  Dec 8, 2008
Compare the efficacy of tenofovir disoproxil fumarate vs adefovir dipivoxil in patients with chronic hepatitis B virus infection. Medscape

Tenofovir Outperforms Adefovir in Chronic HBV  -  Dec 3, 2008
3 -- For patients with chronic hepatitis B infection, the nucleotide reverse transcriptase inhibitor tenofovir (Viread) was more effective than adefovir MedPage Today,

Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for ...  -  Dec 3, 2008
Results At week 48, in both studies, a significantly higher proportion of patients receiving tenofovir DF than of those receiving adefovir dipivoxil had New England Journal of Medicine (subscription),

Data Demonstrating Significant Efficacy of Viread® in Treating ...  -  Dec 3, 2008
For patients with lamivudine-resistant HBV, adefovir dipivoxil should be used in combination with lamivudine. For all patients, consider modifying treatment WELT ONLINE,

Pharmasset Reports Fiscal Year End 2008 Financial Results  -  Dec 11, 2008
Data from one study suggested that clevudine is as effective as entecavir (Baraclude(R)) and that it can be effectively used in combination with adefovir MarketWatch

Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B ...  -  Dec 17, 2008
California, Connecticut, Florida, New York, North Carolina, Ohio, Oregon, Texas, Utah, Virginia, Washington; Australia, China, Greece, Puerto Rico, Taiwan, SmartBrief,

부광 '레보비르' 성장�?�력 본격화  -  Dec 22, 2008
Entecavir 경구제(바�?��?�루드)는 0.5mg �?� 경우 기존�?� 최대 3년간�?� 급여�?�정�?� 하�?�, 3년�?� 초과해 투여하는 경우�?는 Adefovir dipivoxil 과 �?��?�하게 3323�?까지 메디파나뉴스,

Nuevos datos para controlar mejor la hepatitis B y la hepatis C ...  -  Dec 4, 2008
En los trabajos se comparó la eficacia de tenofovir frente a adefovir dipovixil en dos tipos de pacientes, unos eran antígeno e positivos (603) y otros elmundo.es,

Epatite B cronica: terapia farmacologica  -  Dec 18, 2008
Adefovir dipivoxil ( Hepsera ) ha un profilo di resistenza di prima linea superiore, ed è attivo contro i virus HVB resistenti alla Lamivudina. XagenaSalute,

�?�귀�?�약품 엘�?�프�?�제 등 3품목 급여�?�정  -  Dec 22, 2008
...�?� 밖�?�?� 간장질환 용제 adefovir dipivoxil 경구제(품명: 헵세�?�정), clevudine 경구제(품명: 레보비르캡�?), entecavir경구제(품명: 바�?��?�루드정 0.5mg, 시럽), 메디�?�뉴스,

New England Journal of Medicine veröffentlicht Daten, die hohe ...  -  Dec 5, 2008
Bei Patienten mit Lamivudin-resistenter HBV sollte Adefovir Dipivoxil in Kombination mit Lamivudin angewandt werden. Bei allen Patienten sollte eine WELT ONLINE,

Publicados en el New England Journal of Medicine datos que ...  -  Dec 5, 2008
...otro de los medicamentos más recetados para el VHB en Estados Unidos, Hepsera® (adefovir dipivoxil), también desarrollado y comercializado por Gilead. Business Wire (press release),

Data, gepubliceerd in New England Journal of Medicine ...  -  Dec 4, 2008
...orale medicatie voor HBV in de Verenigde Staten, Hepsera® (adefovir dipivoxil), dat eveneens werd ontwikkeld en op de markt wordt gebracht door Gilead. Business Wire (press release),

Tenofovir disoproxil nel trattamento dell’epatite B cronica  -  Dec 2, 2008
I pazienti in entrambi gli studi sono stati assegnati a ricevere Tenofovir disoproxil ( Viread ) oppure Adefovir dipivoxil ( Hepsera ). XagenaSalute,

La rivista New England Journal of Medicine pubblica dati che ...  -  Dec 3, 2008
...dimostrano che Viread è considerevolmente più efficace per il trattamento del virus che causa l’epatite B cronica di Hepsera ® (adefovir dipivoxil), Business Wire (press release),

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.